Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Observational Study With a Control Group to Evaluate the Efficacy and Safety of LPS Adsorption Using the Efferon LPS NEO Device in Children With SepSis (LASSO NEO).

NCT05707494 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.

NCT NCT05707494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05707494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Observational Study With a Control Group to Evaluate the Efficacy and Safety of LPS Adsorption Using the Efferon LPS NEO Device in Children With SepSis (LASSO NEO).
Lead sponsor
Efferon JSC
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2023
Completion date
April 30, 2025
Enrollment
78 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock